RASSF1 and neoplasm: Specific methylation of the RASSF1‐1α promoter and loss of the RASSF1A isoform is a frequent event in many tumor types and offers closer association with cancer progression and poor overall survival (Reeves et al, 2010; Malpeli et al, 2011; Yamashita et al, 2018).